X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Africa

Cipra Medpro Ltd

Yuvraj_pawp by Yuvraj_pawp
8th August 2014
in Africa, Projects

Cipla Medpro Pharmaceuticals is listed on the Johannesburg Securities Exchange and is one of South Africa’s top ten and fastest-growing pharmaceutical groups.

Formerly known as Enaleni Pharmaceuticals Ltd, the company is a leading supplier of chronic and generic medicine.

The Durban-based manufacturing facility, Cipla Medpro Manufacturing has recently undergone a R195m upgrade to international Pharmaceutical Inspection Co-operation Scheme (PIC/s) compliance, making it one of the first in South Africa to boast this accreditation.

The company acquired 100% of Cipla Medpro Products in 2005 for R1.2bn and is now integrating Cipla’s portfolio into its own operation. Cipla is supplying a great amount of Enaleni’s over-the-counter products to be repackaged in India through a 20-year supply contract.

Cipla Medpro reported that sales increased for the first two months of 2007 by 37.5%. The company now hopes to obtain a portion of the South African Government’s retroviral HIV treatment contract, worth $400m over a two-year period.

Refurbishment

In July 2007 new regulations came into force in South Africa from the Medicines Control Council (MCC). The MCC has been working to bring South African companies into compliance with international standards as required by the Pharmaceuticals Inspectorate Cooperation Scheme (PIC/S). The Cipla Medpro facility is the first PIC/S-compliant plant in the country.

The upgrade work was necessary because it was becoming difficult to ensure adherence to the MCC current Good Manufacturing Practice (cGMP) requirements in the old plant, due to ageing equipment.

Because of the enormity of the R125m (€12m) upgrade required for the Cipla Medpro plant, just south of Durban in KwaZulu-Natal, it was closed for several months from June 2007 to allow the first phase of the upgrade/expansion to be carried out more quickly.

“The Cipla Medpro facility is the first PIC/S-compliant plant in the country.”

The plant was able to reopen in September 2007 and obtained its manufacturing license from the MCC, despite phase two work still going on.

Cipla Medpro has worked closely with consultants CTC-Tech who are overseeing the upgrade work, and a number of other world-renowned experts in PIC/S compliance with regards to the new facility and expediting the upgrade.

The work to the 4,000m² plant includes:

  1. A new analytical laboratory
  2. New plant layout
  3. New primary processing equipment
  4. Individual air handling units in every room to control temperature, humidity and airflow
  5. New processes and equipment for tableting, liquids, effervescents and creams
  6. An overall four-fold increase in production capacity
  7. Products

In addition to the company’s own portfolio of brands, which includes Bioharmony, Muscle Science (both divested), FirstPharm Pharmaceutical’s Hercules and Caivil, Cipla Medpro also manufactures on behalf of other companies such as Reckitt Benckiser (Dettol and Disprin), Pharma Dynamics and Merck Generics.

Tags: Africa
Previous Post

GSK’s New Biopharmaceutical Plant

Next Post

AstraZeneca Solid Forms Production Plant

Related Posts

Africa

Teva Announces New Organization Structure and Leadership Changes

27th November 2017
Africa

Rgenix Reports Phase 1a/B Clinical Data Demonstrating Immune-Stimulatory Activity With RGX-104

31st October 2017
Africa

Sancilio Pharma To Present An Update On Research In Sickle Cell At Upcoming National SCDAA Convention

31st October 2017
Europe

Meta-Analysis Using Real-World Data Evaluates Safety Profile of Entyvio® (vedolizumab) in Patients with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

30th October 2017
Africa

Arrakis Therapeutics Announces Release Of SHAPEware Bioinformatics Tools As Open-Source Software

24th October 2017
Africa

Avara pharmaceutical services acquires consumer healthcare facility from gsk in aiken, south carolina

21st September 2017
Next Post

AstraZeneca Solid Forms Production Plant

Latest News

Drug Development

New Delivery Path Brings To Light Efficacy of Immunotherapy

1st April 2023
Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In